Planning for the healthcare burden of hepatitis C infection: Hepatitis C genotypes identified in England, 2002-2007

Journal of Clinical Virology

Volumn 48, Issue 2, 2010, Pages 115-119

  Brant, Lisa J ^a   Ramsay, Mary E ^a   Tweed, Emily ^a   Hale, Antony ^b   Hurrelle, Martin ^b   Klapper, Paul ^c   Ngui, Siew Lin ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Epidemiology; Genotype; Hepatitis C; Surveillance; Trends

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; ASIAN; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; ENGLAND; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PREVALENCE; RNA, VIRAL; YOUNG ADULT;

EID: 77951623216     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2010.03.018     Document Type: Article

References (28)

1. World Health Organisation. Hepatitis C - global prevalence (update). Wkly Epidemiol Rec 49 (1999) 425-427
2. Health Protection Agency. Hepatitis C in the UK, annual report 2008 (2008), Health Protection Agency Centre for Infections, London
3. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., and Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244 4902 (1989) 359-362
4. Zein N.N. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 13 2 (2000) 223-235
5. Mondelli M.U., and Silini E. Clinical significance of hepatitis C virus genotypes. J Hepatol 31 Suppl. 1 (1999) 65-70
6. Harris K.A., Gilham C., Mortimer P.P., and Teo C.G. The most prevalent hepatitis C virus genotypes in England and Wales are 3a and 1a. J Med Virol 58 2 (1999) 127-131
7. Manns M.P., McHutchison J.G., Gordon S.C., Rustgi V.K., Shiffman M., Reindollar R., et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358 9286 (2001) 958-965
8. Hadziyannis S.J., Sette Jr. H., Morgan T.R., Balan V., Diago M., Marcellin P., et al. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 140 5 (2004) 346-355
9. Brant L.J., Ramsay M.E., Balogun M.A., Boxall E., Hale A., Hurrelle M., et al. Diagnosis of acute hepatitis C virus infection and estimated incidence in low- and high-risk English populations. J Viral Hepat 15 12 (2008) 871-877
10. Brant L., Hurrelle M., Balogun M.A., Klapper P., Ahmed F., Boxall E., et al. Sentinel laboratory surveillance of hepatitis C antibody testing in England: understanding the epidemiology of HCV infection. Epidemiol Infect 135 3 (2007) 417-426
11. Brant L., Hurrelle M., Balogun M.A., Klapper P., Ramsay M., and the Hepatitis Sentinel Surveillance Study Group. Where are people being tested for anti-HCV in England? Results from sentinel laboratory surveillance. J Viral Hepat 15 (2008) 729-739
12. Mellor J., Holmes E.C., Jarvis L.M., Yap P.L., and Simmonds P. Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol 76 Pt 10 (1995) 2493-2507
13. Martro E., Gonzalez V., Buckton A.J., Saludes V., Fernandez G., Matas L., et al. Evaluation of a new assay in comparison with reverse hybridization and sequencing methods for hepatitis C virus genotyping targeting both 5′ noncoding and nonstructural 5b genomic regions. J Clin Microbiol 46 1 (2008) 192-197
14. Mortimer J.Y., and Salathiel J.A. 'Soundex' codes of surnames provide confidentiality and accuracy in a national HIV database. Commun Dis Rep CDR Rev 5 12 (1995) R183-R186
15. Nolte F.S. Hepatitis C virus genotyping: clinical implications and methods. Mol Diagn 6 4 (2001) 265-277
16. Cummins C., Winter H., Cheng K.K., Maric R., Silcocks P., and Varghese C. An assessment of the Nam Pehchan computer program for the identification of names of south Asian ethnic origin. J Public Health Med 21 4 (1999) 401-406
17. Rosen H.R., Chou S., Sasaki A.W., and Gretch D.R. Molecular epidemiology of hepatitis C infection in U.S. veteran liver transplant recipients: evidence for decreasing relative prevalence of genotype 1B. Am J Gastroenterol 94 10 (1999) 3015-3019
18. Zhou Y., Wang X., Mao Q., Fan Y., Zhu Y., Zhang X., et al. Changes in modes of hepatitis C infection acquisition and genotypes in southwest China. J Clin Virol 46 3 (2009) 230-233
19. Bourliere M., Barberin J.M., Rotily M., Guagliardo V., Portal I., Lecomte L., et al. Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users. J Viral Hepat 9 1 (2002) 62-70
20. Basaras M., Lombera N., de las H.B., Lopez C., Arrese E., and Cisterna R. Distribution of HCV genotypes in patients infected by different sources. Res Virol 148 5 (1997) 367-373
21. Pujol F.H., and Loureiro C.L. Replacement of hepatitis C virus genotype 1b by genotype 2 over a 10-year period in Venezuela. J Clin Gastroenterol 41 5 (2007) 518-520
22. Roffi L., Ricci A., Ogliari C., Scalori A., Minola E., Colloredo G., et al. HCV genotypes in Northern Italy: a survey of 1368 histologically proven chronic hepatitis C patients. J Hepatol 29 5 (1998) 701-706
23. Soldan K., Barbara J.A., Ramsay M.E., and Hall A.J. Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001. Vox Sang 84 4 (2003) 274-286
24. Soldan K., Davison K., and Dow B.C. Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003. Eurosurveillance 10 2 (2005) 9-10
25. Svirtlih N., Delic D., Simonovic J., Jevtovic D., Dokic L., Gvozdenovic E., et al. Hepatitis C virus genotypes in Serbia and Montenegro: the prevalence and clinical significance. World J Gastroenterol 13 3 (2007) 355-360
26. Savvas S.P., Koskinas J., Sinani C., Hadziyannis A., Spanou F., and Hadziyannis S.J. Changes in epidemiological patterns of HCV infection and their impact on liver disease over the last 20 years in Greece. J Viral Hepat 12 5 (2005) 551-557
27. Hepatitis C in England: an update 2007 (2007), Health Protection Agency Centre for Infections, London
28. National Institute for Clinical Excellence. Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C. NICE Technol Appraisal 75 January (2004) 4-38